Breaking News Instant updates and real-time market news.

BSX

Boston Scientific

$26.39

-2.12 (-7.44%)

07:50
11/29/17
11/29
07:50
11/29/17
07:50

Boston Scientific weakness a buying opportunity, says Canaccord

Canaccord analyst Jason Mills lowered his TAVR estimates as he expects the Lotus delay to have a near to medium-term transient impact on the business. However, he sees a firm bounce back in 2019 and said the weakness in Boston Scientific shares is a buying opportunity. Mills reiterated his Buy rating but lowered his price target to $35 from $36 on Boston Scientific shares.

  • 01

    Dec

  • 14

    Dec

BSX Boston Scientific
$26.39

-2.12 (-7.44%)

11/28/17
WELS
11/28/17
NO CHANGE
WELS
Boston Scientific weakness a buying opportunity, says Wells Fargo
11/28/17
WELS
11/28/17
NO CHANGE
WELS
Outperform
Amid Boston Scientific slide, Wells Fargo finds no new issues with Lotus
Wells Fargo analyst Larry Biegelsen notes that weakness in shares of Boston Scientific followed the company having canceled an investor conference appearance, pointing out that the last time this happened the company then announced a recall of its Lotus TAVR device in Europe. While he attributes the pullback to investor worries about "another shoe to drop," his checks have found no new issues with Lotus, Biegelsen tells investors. Even assuming Lotus revenues were completely removed, he sees a floor for Boston Scientific at $26-$27 per share. Biegelsen maintains an Outperform rating on Boston Scientific, which is down nearly 6% to $26.86 in afternoon trading.
11/29/17
JPMS
11/29/17
NO CHANGE
Target $31
JPMS
Overweight
Boston Scientific selloff yesterday a buying opportunity, says JPMorgan
Boston Scientific last night confirmed speculation by announcing additional delays to its Lotus transcatheter valve program, JPMorgan analyst Michael Weinstein tells investors in a research note. The good news is that the delay is internally driven, the analyst notes after speaking to management. He points out that there are no issues at this point with the European notified body or with the FDA. The issue is manufacturing, Weinstein writes. The analyst is a buyer of Boston Scientific following yesterday's selloff. Despite the Lotus delay, he still thinks the company can grow organic sales by 6% in 2018 and 7%-8% in 2019-2020. Weinstein keeps an Overweight rating on Boston Scientific with a $31 price target.
11/29/17
COWN
11/29/17
NO CHANGE
Target $32
COWN
Outperform
Boston Scientific speculation worse than actual news, says Cowen
Cowen analyst Joshua Jennings noted Boston Scientific shares were weak yesterday prior to the company announcing another setback to the timelines for the Lotus valve system's European reintroduction and U.S. approval and launch. The analyst believes the speculation prior to the release was worse than the actual announcement and he believes there will be little effect on Q4 or 2017 guidance. However, admittedly, the 2018 impact is unknown at this time. Jennings reiterated his Outperform rating and $32 price target on Boston Scientific shares.

TODAY'S FREE FLY STORIES

MGPI

MGP Ingredients

$74.01

0.25 (0.34%)

13:13
12/12/17
12/12
13:13
12/12/17
13:13
Conference/Events
MGP Ingredients management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

13:05
12/12/17
12/12
13:05
12/12/17
13:05
General news
30-Yr Bond Auction Coupon Rate data reported »

30-Yr Bond Auction Coupon…

13:05
12/12/17
12/12
13:05
12/12/17
13:05
General news
30-Yr Bond Auction Total Amount data reported »

30-Yr Bond Auction Total…

RIOT

Riot Blockchain

$23.08

7.22 (45.52%)

13:05
12/12/17
12/12
13:05
12/12/17
13:05
Options
Riot Blockchain Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$21.88

-0.175 (-0.79%)

13:03
12/12/17
12/12
13:03
12/12/17
13:03
Hot Stocks
Twitter adds plus button to simplify making Tweet threads »

Twitter said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

LLY

Eli Lilly

$86.39

-0.28 (-0.32%)

13:03
12/12/17
12/12
13:03
12/12/17
13:03
Hot Stocks
Eli Lilly Canada announces approval of Entuzity KwikPen »

Eli Lilly Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 18

    Jan

  • 31

    Jan

FDC

First Data

$16.60

0.175 (1.07%)

13:02
12/12/17
12/12
13:02
12/12/17
13:02
Conference/Events
First Data management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

WLL

Whiting Petroleum

$24.33

-1.2431 (-4.86%)

13:01
12/12/17
12/12
13:01
12/12/17
13:01
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
12/12/17
12/12
12:55
12/12/17
12:55
Conference/Events
FCC to ho ld a council meeting »

The Communications…

RPD

Rapid7

$18.77

0.03 (0.16%)

12:55
12/12/17
12/12
12:55
12/12/17
12:55
Conference/Events
Rapid7 to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EPAY

Bottomline Technologies

$33.86

0.08 (0.24%)

12:54
12/12/17
12/12
12:54
12/12/17
12:54
Conference/Events
Bottomline Technologies management to meet with Craig-Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$267.13

0.82 (0.31%)

12:51
12/12/17
12/12
12:51
12/12/17
12:51
Hot Stocks
Senator Paul says tax cuts 'are never the problem' »

Senator Rand Paul just…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$267.13

0.82 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:50
12/12/17
12/12
12:50
12/12/17
12:50
General news
Senator Rand Paul tweet »

Senator Rand Paul tweet…

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.94

0.63 (0.24%)

12:45
12/12/17
12/12
12:45
12/12/17
12:45
Hot Stocks
Senator Paul tweets opposition to bills that add to deficit »

Senator Rand Paul just…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.94

0.63 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$157.33

1.92 (1.24%)

12:45
12/12/17
12/12
12:45
12/12/17
12:45
Options
IBM call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

12:35
12/12/17
12/12
12:35
12/12/17
12:35
General news
Treasury 30-year auction preview: the auction is likely to see average results »

Treasury 30-year auction…

KMT

Kennametal

$47.39

1.43 (3.11%)

12:20
12/12/17
12/12
12:20
12/12/17
12:20
Earnings
Kennametal sees FY21 adjusted sales growing to $2.5B-$2.6B »

Sees adjusted gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

KMX

CarMax

$67.59

-0.38 (-0.56%)

12:20
12/12/17
12/12
12:20
12/12/17
12:20
Options
Short-term put buying in Carmax »

Short-term put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

KMT

Kennametal

$47.38

1.415 (3.08%)

12:18
12/12/17
12/12
12:18
12/12/17
12:18
Earnings
Kennametal sees FY18 adjusted sales $2.2B-$2.275B, consensus $2.24B »

Sees FY18 adjusted gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

$NSD

NASDAQ Market Internals

12:17
12/12/17
12/12
12:17
12/12/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/12/17
12/12
12:16
12/12/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNF

FNF Group

$40.39

-0.24 (-0.59%)

12:15
12/12/17
12/12
12:15
12/12/17
12:15
Conference/Events
FNF Group management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

12:10
12/12/17
12/12
12:10
12/12/17
12:10
Conference/Events
Morgan Stanley consumer/tobacco analyst has an analyst/industry conference call »

U.S. Food &…

VLKAY

Volkswagen

$40.48

0.38 (0.95%)

12:10
12/12/17
12/12
12:10
12/12/17
12:10
Periodicals
VW-owned Scania appeals EUR880M EU fine over price fixing, Reuters reports »

Scania, which is owned by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$5.37

-0.035 (-0.65%)

12:10
12/12/17
12/12
12:10
12/12/17
12:10
Options
Change of sentiment in AK Steel »

Change of sentiment in AK…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.